← Leaderboards
Albert Hay Wah Chan
Yale University
$112,160
Attributed
$112,160
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $57.9K · FY2016–17$100K$75K$50K$25K$0
'16
'17
Funding mix
By agency
NIH$112,160 · 1
By mechanism
F32$112,160 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- William Jorgensen$15,848,158
- Karen S Anderson$26,797,421
- Elinore F. McCance-Katz$13,032,111
- Craig M Crews$33,790,660
- Yung-Chi Cheng$16,454,542
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeAdverse EffectsActive SitesAnti-Hiv AgentsAntiviral AgentsBaseAffinityBiologyCatecholsCellsCombined Modality TherapyComplexComputing MethodologiesCrystallizationBindingCytotoxicityDesignDissociationDockingDrug DesignDrug ResistanceDrug TargetingEnzyme Inhibitor DrugsEnzymes
Grant awards (3)
Optimizing HIV reverse transcriptase inhibitors through structural, kinetic and cellular approaches$57,066
F32 · FY2017 · AI · contact PI
Optimizing HIV reverse transcriptase inhibitors through structural, kinetic and cellular approaches$800
F32 · FY2017 · AI · contact PI
Optimizing HIV reverse transcriptase inhibitors through structural, kinetic and cellular approaches$54,294
F32 · FY2016 · AI · contact PI